pCD5-PR8-TEV-sfGFP-twinStrep
(Plasmid
#157933)
-
PurposeExpresses influenza A virus trimeric hemagglutinin fused to a sfGFP
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 157933 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCD5
-
Backbone manufacturer-
- Backbone size w/o insert (bp) 3500
- Total vector size (bp) 6500
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin and Tetracycline, 100 & 10 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)MC1061
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert nameA/PuertoRico/8/34 hemagglutinin
-
SpeciesSynthetic
-
Insert Size (bp)1500
-
MutationE190D
-
Entrez GeneHA (a.k.a. FLUAVs4gp1)
- Promoter CMV
-
Tag
/ Fusion Protein
- sfGFP & TwinStrep (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NheI (not destroyed)
- 3′ cloning site PacI (not destroyed)
- 5′ sequencing primer GGC TAA CTA GAG AAC CCA CTG C
- 3′ sequencing primer TTC AGG GGG AGG TGT GGG AG (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCD5-PR8-TEV-sfGFP-twinStrep was a gift from Robert de Vries (Addgene plasmid # 157933 ; http://n2t.net/addgene:157933 ; RRID:Addgene_157933) -
For your References section:
Fluorescent Trimeric Hemagglutinins Reveal Multivalent Receptor Binding Properties. Nemanichvili N, Tomris I, Turner HL, McBride R, Grant OC, van der Woude R, Aldosari MH, Pieters RJ, Woods RJ, Paulson JC, Boons GJ, Ward AB, Verheije MH, de Vries RP. J Mol Biol. 2019 Feb 15;431(4):842-856. doi: 10.1016/j.jmb.2018.12.014. Epub 2018 Dec 29. 10.1016/j.jmb.2018.12.014 PubMed 30597163